Eyes on Oncology – Navigating corneal adverse events associated with antibody drug conjugates in oncology

The Master Clinician Alliance (MCA) is providing a Section 3 accredited online self-assessment program focusing on ocular AE assessment and management. Navigate through a learning path that includes a pre- and post-questionnaire, patients cases, knowledge questions as well as presentations.

QUICK AND EASY PARTICIPATION, NO ZOOM MEETINGS! Simply complete the program on your own, conveniently from your mobile device or computer. The program is expected to take about 1 hour to complete. Please note that the program is available in English and French.

Learning objectives:

By the end of this learning session, you will be able to:

  1. Describe the mechanisms of action and design of antibody drug conjugates (ADCs)
  2. Recognize the corneal toxicities caused by ADCs and propose appropriate corneal adverse event (AE) management strategies to minimize ocular complications
  3. Implement effective communication and coordination strategies to enhance collaborative care for oncology patients experiencing corneal toxicities

To register for this self-assessment program, please click HERE.